Michael Manns

TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings.

Part of Universitätsklinikum Freiburg, Universitäts-Herzzentrum Freiburg-Bad Krozingen GmbH is a cutting-edge medical center that provides the latest medical standards to its patients. The center is located in Bad Krozingen, Germany, and is involved in research to gain new insights into the causes and mechanisms of diseases of the cardiovascular system. The center also researches the influences of the environment and lifestyle on the development of these diseases and looks for ways to prevent them. Despite all scientific and methodical demands, the patients and their needs are the center's priority. The center has an interdisciplinary team that cares for around 22,000 inpatients every year. The German company was founded in 2012, and the CEOs are Frederik Wenz and Anja Simon. Universitäts-Herzzentrum Freiburg-Bad Krozingen was acquired by Universitätsklinikum Freiburg on July 09, 2020.

Medine GmbH engages in the holding of participating interests in firms. It also manages its own assets and provides business consulting services. The company was founded on August 15, 2008 and is headquartered in Mainz, Germany.

reBOOST Management GmbH engages in the acquisition, management, and sale of firms. It also offers management and consulting services. The company was founded on August 23, 2018 and is headquartered in Mainz, Germany.

Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting.